MIRMEHRABI MAHMOUD
No ORCID on file
· 75 papers in corpus
· active 2008
Frequent coauthors
- TADAYON ABDOLSAMAD 75
- DESHMUKH SUBODH 75
- NIU YUPING 45
- KU MANNCHING SHERRY 30
- LIANG JENNIFER Q 15
- CONSIDINE JOHN LEO 15
- WU YANZHONG 15
2008
Novel polymorph Form II and III, solvate Forms I, II, III, and IV, and the hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1H-pyrrole-2-carbonitrile are provided, as are methods for preparing the s…
2008
Novel polymorph Form II and III, solvate Forms I, II, III, and IV, and the hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1H-pyrrole-2-carbonitrile are provided, as are methods for preparing the s…
2008
Novel polymorph Form II and III, solvate Forms I, II, III, and IV, and the hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1H-pyrrole-2-carbonitrile are provided, as are methods for preparing the s…
2008
Novel polymorph Form II and III, solvate Forms I, II, III, and IV, and the hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1H-pyrrole-2-carbonitrile are provided, as are methods for preparing the s…
2008
Novel polymorph Form II and III, solvate Forms I, II, III, and IV, and the hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1H-pyrrole-2-carbonitrile are provided, as are methods for preparing the s…
2008
Novel polymorph Form II and III, solvate Forms I, II, III, and IV, and the hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1H-pyrrole-2-carbonitrile are provided, as are methods for preparing the s…
2008
Novel polymorph Form II and III, solvate Forms I, II, III, and IV, and the hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1H-pyrrole-2-carbonitrile are provided, as are methods for preparing the s…
2008
Novel polymorph Form II and III, solvate Forms I, II, III, and IV, and the hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1H-pyrrole-2-carbonitrile are provided, as are methods for preparing the s…
2008
Novel polymorph Form II and III, solvate Forms I, II, III, and IV, and the hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1H-pyrrole-2-carbonitrile are provided, as are methods for preparing the s…
2008
Novel polymorph Form II and III, solvate Forms I, II, III, and IV, and the hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1H-pyrrole-2-carbonitrile are provided, as are methods for preparing the s…
2008
Novel polymorph Form II and III, solvate Forms I, II, III, and IV, and the hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1H-pyrrole-2-carbonitrile are provided, as are methods for preparing the s…
2008
Novel polymorph Form II and III, solvate Forms I, II, III, and IV, and the hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1H-pyrrole-2-carbonitrile are provided, as are methods for preparing the s…
2008
Novel polymorph Form II and III, solvate Forms I, II, III, and IV, and the hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1H-pyrrole-2-carbonitrile are provided, as are methods for preparing the s…
2008
Novel polymorph Form II and III, solvate Forms I, II, III, and IV, and the hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1H-pyrrole-2-carbonitrile are provided, as are methods for preparing the s…
2008
Novel polymorph Form II and III, solvate Forms I, II, III, and IV, and the hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1H-pyrrole-2-carbonitrile are provided, as are methods for preparing the s…
2008
A polymorph Form III of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile and methods of preparing Form III are described. Also provided are methods of contraception, treating or preventing fibroids, uterine leiomyomata, end…
2008
A polymorph Form III of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile and methods of preparing Form III are described. Also provided are methods of contraception, treating or preventing fibroids, uterine leiomyomata, end…
2008
A polymorph Form III of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile and methods of preparing Form III are described. Also provided are methods of contraception, treating or preventing fibroids, uterine leiomyomata, end…
2008
A polymorph Form III of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile and methods of preparing Form III are described. Also provided are methods of contraception, treating or preventing fibroids, uterine leiomyomata, end…
2008
A polymorph Form III of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile and methods of preparing Form III are described. Also provided are methods of contraception, treating or preventing fibroids, uterine leiomyomata, end…
2008
A polymorph Form III of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile and methods of preparing Form III are described. Also provided are methods of contraception, treating or preventing fibroids, uterine leiomyomata, end…
2008
A polymorph Form III of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile and methods of preparing Form III are described. Also provided are methods of contraception, treating or preventing fibroids, uterine leiomyomata, end…
2008
A polymorph Form III of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile and methods of preparing Form III are described. Also provided are methods of contraception, treating or preventing fibroids, uterine leiomyomata, end…
2008
A polymorph Form III of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile and methods of preparing Form III are described. Also provided are methods of contraception, treating or preventing fibroids, uterine leiomyomata, end…
2008
A polymorph Form III of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile and methods of preparing Form III are described. Also provided are methods of contraception, treating or preventing fibroids, uterine leiomyomata, end…